Europe HbA1c Testing market is expected to be valued at USD 550 Million by 2023 Overview: The HbA1c test is used to detect and diagnose diabetes and prediabetes in patients. The globular hemoglobin molecule binds to glucose, which gives rise to the glycosylated hemoglobin molecule called hemoglobin A1C (HbA1C). Patients with high glucose have more HbA1C present in the blood. The average blood glucose of a person can be diagnosed by measuring this molecule of glycosylated hemoglobin. It is important for the diabetic patient to know the glucose level because there may be a risk of diabetes-related complications. The HbA1c test is considered more effective than the control of blood glucose. The blood glucose level gives the presence of glucose at a given time, while the HbA1c test provides blood glucose for 2 to 3 months. View sample and decide: https://www.marketdataforecast.com/market-reports/europe-glycatedhaemoglobin-testing-market-5127/request-sample Europe Glycated Haemoglobin Testing Market size was around USD 320 Million in 2018. It is expected to grow at a CAGR of 11.32% to reach USD 550 Million by 2023. Drivers and Restraints: Growing awareness about diabetes preventive care, rise in diabetes population, increase in geriatic population, upgrading technology advancement, physicians are increasingly prescribing HbA1 test to their patients. However high cost of the devices and limitations for the results of certain population like pregnant women, elder people is going to hamper the market. To know more read: https://www.marketdataforecast.com/market-reports/europe-glycatedhaemoglobin-testing-market-5127/ Geographic Segmentation The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. Europe accounted for the second largest share of the market. Get your customized report: https://www.marketdataforecast.com/market-reports/europe-glycatedhaemoglobin-testing-market-5127/customize-report Major companies in the market are Transasia Biomedical ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc. Scope of the report: The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated. The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: [email protected] Organization: MarketDataForecast™ Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626

Europe HbA1c Testing Market By Type (Hand Held Devices, Bench Top Devices), Technology (Ion-Exchange HPCL, Enzymatic Assay, Affinity Binding Chromatography Turbidimetric Inhibition Immunoassay And Other)